Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging Study
journal contribution
posted on 2023-11-15, 02:41authored byGernot Klein, Marcella Petrone, Ye Yang, Thuong HoangThuong Hoang, Sheila Hazlett, Lars Hansen, Armando Flor
Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging Study